Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (21)
Luca Degli Esposti, Valentina Perrone, Diego Sangiorgi, Stefania Saragoni, Melania Dovizio, Flavio Caprioli, Fernando Rizzello, Marco Daperno & Alessandro Armuzzi. (2024) Estimation of patients affected by inflammatory bowel disease potentially eligible for biological treatment in a real-world setting. Digestive and Liver Disease 56:1, pages 29-34.
Crossref
Crossref
Yu Nishida, Shuhei Hosomi, Yumie Kobayashi, Rieko Nakata, Masaki Ominami, Yuji Nadatani, Shusei Fukunaga, Koji Otani, Fumio Tanaka, Yasuaki Nagami, Koichi Taira, Noriko Kamata & Yasuhiro Fujiwara. (2023) Impact of the COVID-19 Pandemic on the Lifestyle and Psychosocial Behavior of Patients with Inflammatory Bowel Diseases: A Narrative Review. Healthcare 11:19, pages 2642.
Crossref
Crossref
Alex Arenas, María José Moreta, Ingrid Ordás, Agnès Fernández-Clotet, Berta Caballol, Marta Gallego, Alejandro Vara, Rebeca Barastegui, Angel Giner, Cristina Prieto, Maria Carme Masamunt, Roberto Candia & Elena Ricart. (2023) De-escalating therapy in inflammatory bowel disease: Results from an observational study in clinical practice. Gastroenterología y Hepatología.
Crossref
Crossref
Maojuan Li, Yan Tao, Yang Sun, Jing Wu, Fengrui Zhang, Yunling Wen, Min Gong, Jingxian Yan, Hao Liang, Xinyu Bai, Junkun Niu & Yinglei Miao. (2023) Constructing a prediction model of inflammatory bowel disease recurrence based on factors affecting the quality of life. Frontiers in Medicine 10.
Crossref
Crossref
Remi Mahmoud, Edo H.J. Savelkoul, Wout Mares, Rogier Goetgebuer, Ben J.M. Witteman, Daan B. de Koning, Sebastiaan A.C. van Tuyl, Itta Minderhoud, Maurice W.M. D. Lutgens, Dilek Akol-Simsek, Fiona D.M. van Schaik, Herma H. Fidder, Jeroen M. Jansen, Petra G.A. van Boeckel, Nofel Mahmmod, Carmen S. Horjus-Talabur Horje, Tessa E.H. Römkens, Jean-Frédéric Colombel, Frank Hoentjen, Bindia Jharap & Bas Oldenburg. (2023) Complete Endoscopic Healing Is Associated With Lower Relapse Risk After Anti-TNF Withdrawal in Inflammatory Bowel Disease. Clinical Gastroenterology and Hepatology 21:3, pages 750-760.e4.
Crossref
Crossref
Annemay M. H. Stoker, Leslie Logghe, Mirjam C. M. van der Ende-van Loon, Erik J. Schoon, Ramon-Michel Schreuder, Arnold Stronkhorst & Lennard P. L. Gilissen. (2023) Relapse rates after withdrawal versus maintaining biologic therapy in IBD patients with prolonged remission. Clinical and Experimental Medicine 23:6, pages 2789-2797.
Crossref
Crossref
Cong Dai, Yi-Nuo Wang, Wen-Ning Tian, Yu-Hong Huang & Min Jiang. (2023) Long-term clinical outcomes after the discontinuation of anti-TNF agents in patients with inflammatory bowel disease: a meta-analysis. Revista Española de Enfermedades Digestivas.
Crossref
Crossref
Sebastiaan ten Bokkel Huinink, Djuna C. de Jong, Daan Nieboer, Doranne Thomassen, Ewout W. Steyerberg, Marcel G.W. Dijkgraaf, Alexander G.L. Bodelier, Rachel L. West, Tessa E.H. Römkens, Frank Hoentjen, Rosalie C. Mallant, Bas A.C. van Tuyl, Wout G.N. Mares, Frank H.J. Wolfhagen, Gerard Dijkstra, Jurriën G.P. Reijnders, Nanne K. de Boer, Adriaan C.I.T.L. Tan, Petra G.A. van Boeckel, Greetje J. Tack, Dirk P. van Asseldonk, Geert R.A.M. D’Haens, C Janneke van der Woude, Marjolijn Duijvestein & Annemarie C de Vries. (2022) Validation and update of a prediction model for risk of relapse after cessation of anti-TNF treatment in Crohn’s disease. European Journal of Gastroenterology & Hepatology 34:10, pages 983-992.
Crossref
Crossref
C Cottron, X Treton, R Altwegg, C Reenaers, A Amiot, M Fumery, L Vuitton, L Peyrin-Biroulet, G Bouguen, O Dewit, S Nancey, L Caillo, X Roblin, M Beylot-Barry, P Rivière & D Laharie. (2022) How to Manage Inflammatory Bowel Disease Patients When They Withdraw Anti-Tumour Necrosis Factor [Anti-TNF] Due to Severe Anti-TNF-Induced Skin Lesions? A Multicentre Cohort Study. Journal of Crohn's and Colitis 16:8, pages 1202-1210.
Crossref
Crossref
Renske W.M. Pauwels, C. Janneke van der Woude, Daan Nieboer, Ewout W. Steyerberg, María J. Casanova, Javier P. Gisbert, Nick A. Kennedy, Charlie W. Lees, Edouard Louis, Tamás Molnár, Kata Szántó, Eduardo Leo, Steven Bots, Robert Downey, Milan Lukas, Wei C. Lin, Aurelien Amiot, Cathy Lu, Xavier Roblin, Klaudia Farkas, Jakob B. Seidelin, Marjolijn Duijvestein, Geert R. D’Haens, Annemarie C. de Vries, Annemarie C. de Vries, Renske W.M. Pauwels, C. Janneke van der Woude, Daan Nieboer, Ewout W. Steyerberg, Jasmijn A.M. Sleutjes, Marjolijn Duijvestein, Geert R. D’Haens, María J. Casanova, Javier P. Gisbert, Nick A. Kennedy, Charlie W. Lees, Edouard Louis, Tamás Molnár, Kata Szántó, Eduardo Leo, José M. García-Ortiz, Robert Downey, Alenka J. Brooks, Peter J. Hamlin, Shaji Sebastian, Alan J. Lobo, Milan Lukas, Wei C. Lin, Aurelien Amiot, Cathy Lu, Levinus (Leo) A. Dieleman, Xavier Roblin, Shomron Ben-Horin, Klaudia Farkas, Jakob B. Seidelin, Casper Steenholdt & Steven Bots. (2022) Prediction of Relapse After Anti–Tumor Necrosis Factor Cessation in Crohn’s Disease: Individual Participant Data Meta-analysis of 1317 Patients From 14 Studies. Clinical Gastroenterology and Hepatology 20:8, pages 1671-1686.e16.
Crossref
Crossref
Hiroshi Keino, Takayo Watanabe, Makiko Nakayama, Yoshinori Komagata, Kazuhito Fukuoka & Annabelle A Okada. (2021) Long-term efficacy of early infliximab-induced remission for refractory uveoretinitis associated with Behçet’s disease. British Journal of Ophthalmology 105:11, pages 1525-1533.
Crossref
Crossref
Joseph Meredith, Paul Henderson, David C. Wilson & Richard K. Russell. (2021) Combination Immunotherapy Use and Withdrawal in Pediatric Inflammatory Bowel Disease—A Review of the Evidence. Frontiers in Pediatrics 9.
Crossref
Crossref
Andreas Blesl, Lukas Binder, Christoph Högenauer, Heimo Wenzl, Andrea Borenich, Gudrun Pregartner, Andrea Berghold, Sigrid Mestel, Patrizia Kump, Franziska Baumann‐Durchschein & Wolfgang Petritsch. (2021) Limited long‐term treatment persistence of first anti‐TNF therapy in 538 patients with inflammatory bowel diseases: a 20‐year real‐world study. Alimentary Pharmacology & Therapeutics 54:5, pages 667-677.
Crossref
Crossref
María José Casanova, María Chaparro, Óscar Nantes, José Manuel Benítez, María Rojas‐Feria, Jesús Castro‐Poceiro, José María Huguet, Albert Martín‐Cardona, Marta Aicart‐Ramos, Joan Tosca, María del Mar Martín‐Rodríguez, Carlos González‐Muñoza, Miriam Mañosa, Eduardo Leo‐Carnerero, Luis Javier Lamuela‐Calvo, Isabel Pérez‐Martínez, Luis Bujanda, Joaquín Hinojosa, Ramón Pajares, Federico Argüelles‐Arias, José Lázaro Pérez‐Calle, Gloria Esther Rodríguez‐González, Jordi Guardiola, Manuel Barreiro‐de Acosta & Javier P. Gisbert. (2021) Clinical outcome after anti‐tumour necrosis factor therapy discontinuation in 1000 patients with inflammatory bowel disease: the EVODIS long‐term study. Alimentary Pharmacology & Therapeutics 53:12, pages 1277-1288.
Crossref
Crossref
Antonello Di Paolo & Giacomo Luci. (2021) Personalized Medicine of Monoclonal Antibodies in Inflammatory Bowel Disease: Pharmacogenetics, Therapeutic Drug Monitoring, and Beyond. Frontiers in Pharmacology 11.
Crossref
Crossref
Laurent Peyrin-Biroulet, William J. Sandborn, Remo Panaccione, Eugeni Domènech, Lieven Pouillon, Britta Siegmund, Silvio Danese & Subrata Ghosh. (2021) Tumour necrosis factor inhibitors in inflammatory bowel disease: the story continues. Therapeutic Advances in Gastroenterology 14, pages 175628482110599.
Crossref
Crossref
Kayle Dickson, Hajer Malitan & Christian Lehmann. (2020) Imaging of the Intestinal Microcirculation during Acute and Chronic Inflammation. Biology 9:12, pages 418.
Crossref
Crossref
Panupong Hansrivijit, Max M. Puthenpura, Charat Thongprayoon, Himmat S. Brar, Tarun Bathini, Karthik Kovvuru, Swetha R. Kanduri, Karn Wijarnpreecha & Wisit Cheungpasitporn. (2020) Incidence and Impacts of Inflammatory Bowel Diseases among Kidney Transplant Recipients: A Meta-Analysis. Medical Sciences 8:3, pages 39.
Crossref
Crossref
Konstantinos Papamichael & Adam S. Cheifetz. (2020) Therapeutic drug monitoring in patients on biologics: lessons from gastroenterology. Current Opinion in Rheumatology 32:4, pages 371-379.
Crossref
Crossref
Xue-Liang Sun, Shi-Yi Chen, Shan-Shan Tao, Li-Chao Qiao, Hong-Jin Chen & Bo-Lin Yang. (2020) Optimized timing of using infliximab in perianal fistulizing Crohn's disease. World Journal of Gastroenterology 26:14, pages 1554-1563.
Crossref
Crossref
E. Yu. Chashkova, N. S. Korotayeva, E. E. Kunetsova, V. G. Gorokhova & E. V. Soboleva. (2019) Assessment of the State of Cell Membranes against the Background of Prolonged Use of Anticytokine Therapy in Patients with Ulcerative Colitis. Acta Biomedica Scientifica (East Siberian Biomedical Journal) 4:5, pages 84-90.
Crossref
Crossref